Beyond cellular analysis, advancements in molecular imaging, such as PET scans using specific tracers designed to target mutant proteins, are under investigation, potentially allowing direct visualization of EGFR mutations within tumor sites (10). This evidence concerns the gene EGFR and neoplasm.